Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $18
Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $18
Sabra Healthcare REIT Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Sabra Health Care REIT Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Citigroup Upgrades Sabra Health Care REIT to Buy From Neutral, Price Target Is $20
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Maintains Target Price $18
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Sabra Healthcare REIT Price Target Raised to $17.00/Share From $15.00 by Scotiabank
Sabra Health Care REIT Analyst Ratings
Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $17
Sabra Healthcare REIT (SBRA) Gets a Hold From Wells Fargo
Sabra Health Care REIT Analyst Ratings
Truist Adjusts Price Target on Sabra Health Care REIT to $16 From $15, Maintains Buy Rating
Scotiabank: Maintaining the Sabra Health Care REIT (SBRA.US) rating, adjusted from being flat with the market to being flat with the market, and the target price was adjusted from $14.00 to $15.00.
Sabra Health Care REIT Analyst Ratings
Scotiabank Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)
Deutsche Bank Initiates Coverage On Sabra Health Care REIT With Buy Rating, Announces Price Target of $21